Intervention for Depression in Underserved Geriatric Populations
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depression in Old Age
- Sponsor
- University of Ibadan
- Enrollment
- 110
- Primary Endpoint
- Depression remission
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The aim of this hybrid (Effectiveness-Implementation) cluster randomised controlled clinical trial is to test the feasibility of implementing an age-appropriate electronic version of the WHO Mental Health Gap Action Programme Intervention Guide (emhGAP-Age) in routine home-based care of older Nigerians with depression. The main questions it aims to answer are:
-
Whether the emhGAP-Age demonstrate sufficient signals of effectiveness in the identification and home management of late life depression to permit for further exploration in a fully powered clinical trial?
-
What are the logistical, programmatic, and operational requirements for a home-delivered emhGAP-Age in a sample of older people with depression in Nigeria? Consenting older participants with depression in the intervention arm will receive treatment based on emhGAP-Age which consists of;
- Adapted electronic generic version of the WHO Mental Health Gap Action Programme Intervention Guide (emhGAP-IG)
- Adapted Problem-Solving Therapy (PST-PC)
- Support/supervision of providers
- Links to social support resources. Researchers will compare with treatment based on the basic specification in the generic emhGAP-IG (consisting of basic psychoeducation and stress reduction) for effects on depression remission.
Investigators
Akin Ojagbemi
Senior Lecturer
University of Ibadan
Eligibility Criteria
Inclusion Criteria
- •Age ≥ 60 years,
- •PHQ-9 score of ≥11 during routine consultation
Exclusion Criteria
- •Severe co-morbidity requiring urgent attention.
- •Severe cognitive impairment/dementia (Community Screening Instruments for Dementia score≤ 20) .
- •Active suicidal intention.
- •Evidence of bipolar/psychosis/severe substance use disorders.
- •Planning to move out of the study catchment area within 6 months.
- •Refusing/lacking capacity to consent/accent
Outcomes
Primary Outcomes
Depression remission
Time Frame: At six months post trial entry
Patient Health Questionnaire (PHQ-9) score \< 6